Insulet begins construction on $100M Acton facility
Zachary Comeau
Insulet is expected to begin operating this space in Acton by the beginning of 2019.
Insulet, a maker of an insulin management device for patients with diabetes, has broken ground on a new facility in Nagog Park in Acton the company said should represent an investment of about $100 million.
The company has been operating a manufacturing plant in China for five years, but now it's building a $100-million facility in Nagog Park in Acton. It purchased a vacant office building for $9.25 million earlier this year and is expanding the building to more than 300,000 square feet. The nearly 26-acre site will allow for future expansion.
The facility -- expected to produce hundreds of jobs but rely heavily on automation -- will be able to produce up to 70 percent more devices with up to 90 percent fewer employees compared to all four of the company's current manufacturing lines in China, according to a press release announcing the sale in February.
To reduce risk associated with transporting the products to the company's main customer base in the U.S., the company opted to open a redundant operation stateside, said Chuck Alpuche, executive vice president of global manufacturing and supply chain operations.
The facility is expected to be operational by the beginning of 2019.
WBJ Web Partners
Most Recent
Most Recent
0 Comments